GENE THERAPY STUDY GROUP

The Work Group on Gene Therapy in Arthritis presented data in Marseille, 27 February 2003. The group is active, with a high quality of scientific exchange, as the field of gene therapy is changing. One major limitation for the clinical application of gene therapy in joint diseases is the safety of the procedure and the available vectors. The gene therapy trial conducted on 11 SCID children was shortened because of leukaemia induced by the vector. The oncogene activation was shown to be …